Evidence map›Paper›PMID 40579653›Full record

ArticleInsights into imaging2025

Explainable multi-modal radiomics for early prediction of liver metastasis in rectal cancer: a multicentric study.

Yaru Feng, Jing Gong, Yanyan Wang, Yanfen Cui, Tong Tong

Abstract read
In one paragraph

Article in Insights into imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yaru Feng *Department of Radiology, Fudan University Shanghai Cancer Center and Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, P. R. China.
Jing Gong *Department of Radiology, Fudan University Shanghai Cancer Center and Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, P. R. China.
Yanyan WangDepartment of Radiology, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, P. R. China.
Yanfen CuiDepartment of Radiology, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, P. R. China. yanfen210@126.com.ORCID http://orcid.org/0000-0001-6631-5687
Tong TongDepartment of Radiology, Fudan University Shanghai Cancer Center and Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, P. R. China. t983352@126.com.ORCID http://orcid.org/0000-0002-9180-8181

Funding

National Natural Science Foundation of China 82271946Shanghai Hospital Development Center SHDC2023CRD014
6 · The paper itself

Abstract

objectivesTo enhance liver metastasis (LM) risk prediction for rectal cancer (RC) patients using a multi-modal, explainable radiomics model based on rectal MRI and whole-liver CT, and to assess its prognostic value for survival.

methodsThis retrospective study enrolled patients with pathologically confirmed RC from two medical centers. Radiomics features were extracted from rectal MRI as well as pre-metastatic liver CT. Feature selection was performed using ANOVA F-value and recursive feature elimination. The SHAP method elucidated the model's functionality by highlighting key feature contributions. Finally, Kaplan-Meier survival analysis and Cox regression assessed the prognostic utility of the model's prediction score.

resultsA total of 431 patients were enrolled from two centers in our study. The radiomics model developed from baseline whole-liver CT features alone could predict LM development in all cohorts. A fusion model integrating liver CT with primary tumor MRI features provided synergetic effect and was more efficient in predicting LM, displaying an area under the receiver operating curve (AUC) of 0.85 (95% CI: 0.80-0.90) in the training cohort, and AUC values of 0.75 (95% CI: 0.64-0.86) and 0.73 (95% CI: 0.61-0.85) in the internal and external validation cohorts, respectively. SHAP summary plots illustrated how feature values influenced their impact on the model. The risk score generated by our model demonstrated significant prognostic value for LM-free survival (LMFS).

conclusionsThe multi-modal, explainable radiomics model integrating primary tumor and pre-metastatic liver radiomics enhances the prediction of LM development and provides prognostic value in RC patients. CRITICAL RELEVANCE STATEMENT: This study demonstrates that integrating radiomics features from pre-metastatic liver and primary tumors enhances the predictive performance for liver metastasis development in rectal cancer patients, highlighting its potential for personalized treatment planning and follow-up strategies for rectal cancer patients. KEY POINTS: Pre-metastatic liver CT radiomics features could predict the liver metastasis development of rectal cancer. Integrating primary tumor and pre-metastatic liver radiomics improved liver metastasis prediction accuracy. The model demonstrated favorable interpretability through SHAP method.

Indexed as

Liver metastasisPredictionRadiomicsRectal cancer

Identifiers

PMID40579653
PMCPMC12205110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.